Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04925570 · ClinicalTrials.gov registry record · Phase 2
The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use
A Phase 2 study, sponsored by Woebot Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 258
- Enrollment target
NCT04925570 is a Phase 2 study that has completed, run by Woebot Health. The registered enrollment target is 258 participants.
The verdict
NCT04925570, a Phase 2 study, has completed, sponsored by Woebot Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 258 participants
- Enrollment target
Study Summary
This study aims to validate W-SUDs as a digitally-delivered substance use disorder program through a fully-powered randomized control trial that will test the comparative efficacy of the mobile-app based substance use disorder program (W-SUDs) to reduce substance use relative to a psychoeducation control condition, which has no cognitive behavioral therapy and the content is not delivered through a conversational user interface.
Interventions
- DEVICE W-SUDs
- OTHER Digitally-delivered Psychoeducation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 258 participants |
| Start Date | 2022-11-14 |
| Est. Completion | 2023-08-17 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04925570
The ClinicalTrials.gov registry entry for NCT04925570 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Woebot Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which W-SUDs is the first listed.
NCT04925570 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04925570 about?
NCT04925570 is a clinical study titled "The Anchor Study: Digitally Delivered Intervention for Reducing Problematic Substance Use". This study aims to validate W-SUDs as a digitally-delivered substance use disorder program through a fully-powered randomized control trial that will test the comparative efficacy of the mobile-app based substance use disorder program (W-SUDs) to reduce substance use relative to a psychoeducation co...
What is the current status of trial NCT04925570?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 258 participants. The study started on 2022-11-14. Estimated completion is 2023-08-17.
What interventions are being tested in trial NCT04925570?
The interventions under investigation include: W-SUDs (DEVICE), Digitally-delivered Psychoeducation (OTHER).
Who is sponsoring clinical trial NCT04925570?
This trial is sponsored by Woebot Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.